Anti-CD44 antibody [SP37] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CD44 antibody. Carrier free. Suitable for WB, IHC-P, Flow Cyt and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [SP37] - BSA and Azide free (AB236436)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human esophageal carcinoma tissue sections labeling CD44 with Purified ab101531 at 1/100 dilution (1.03 µg/ml). Heat mediated antigen retrieval was performed Heat mediated antigen retrieval with sodium citrate buffer (pH 6.0, epitope retrieval solution 1) for 20mins. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab101531)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [SP37] - BSA and Azide free (AB236436)
Formalin-fixed, paraffin-embedded human esophageal carcinoma tissue stained for CD44 with ab101531 at a 1/100 dilution in immunohistochemical analysis.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA and sodium azide (ab101531).
- Flow Cyt
Lab
Flow Cytometry - Anti-CD44 antibody [SP37] - BSA and Azide free (AB236436)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab101531).
Flow cytometric analysis of Jurkat (human T cell leukemia T lymphocyte from peripheral blood, Left) / A549 (human lung carcinoma epithelial cell, Right) cells labelling CD44 with ab101531 at 1/50 dilution (1µg) (Red) followed by a Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) secondary antibody used at a 1/5000 dilution compared with a Rabbit monoclonal IgG (ab172730) ( Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Gated on viable cells.
Negative control : Jurkat.
- WB
Lab
Western blot - Anti-CD44 antibody [SP37] - BSA and Azide free (AB236436)
False colour image of Western blot : Anti-CD44 antibody [SP37] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab101531 was shown to bind specifically to CD44. A band was observed at 75-80 kDa in wild-type HeLa cell lysates with no signal observed at this size in CD44 knockout cell line ab262515 (knockout cell lysate ab263938). To generate this image, wild-type and CD44 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CD44 antibody [SP37] (<a href='/en-us/products/primary-antibodies/cd44-antibody-sp37-ab101531'>ab101531</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
CD44 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human CD44 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cd44-knockout-hela-cell-line-ab262515'>ab262515</a>)
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
LNCaP cell lysate at 20 µg
Predicted band size: 81 kDa
Observed band size: 75-80 kDa
false
- WB
Lab
Western blot - Anti-CD44 antibody [SP37] - BSA and Azide free (AB236436)
This data was developed using the same antibody clone in a different buffer formulation (ab101531).
Lanes 1 - 4 : Merged signal (red and green). Green - ab101531 observed at 80 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab101531 was shown to react with CD44 in wild-type HeLa cells in western blot. Loss of signal was observed when CD44 knockout sample was used. Wild-type HeLa and CD44 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab101531 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD44 antibody [SP37] (<a href='/en-us/products/primary-antibodies/cd44-antibody-sp37-ab101531'>ab101531</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
CD44 knockout HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CD44 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cd44-knockout-hela-cell-line-ab262515'>ab262515</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
LNCaP (Human prostate cancer cell line) whole cell lysate at 20 µg
Predicted band size: 81 kDa
Observed band size: 80 kDa
false
Related conjugates and formulations (8)
-
Anti-CD44 antibody [SP37]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD44 antibody [SP37]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD44 antibody [SP37]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD44 antibody [SP37]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD44 antibody [SP37]
-
578 PE
PE Anti-CD44 antibody [SP37]
-
660 APC
APC Anti-CD44 antibody [SP37]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CD44 antibody [SP37]
Reactivity data
Product details
ab236436 is the carrier-free version of ab101531.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Cancer immunology, immunotherapy : CII 74:107 PubMed39932546
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com